Early introduction of Heparin in DIC reduces mortality risk

Written By :  Jacinthlyn Sylvia
Medically Reviewed By :  Dr. Kamal Kant Kohli
Published On 2022-09-02 14:30 GMT   |   Update On 2023-10-19 11:34 GMT

A new study published in the International Journal of Clinical Practice suggests that heparin introduction during early stages of disseminated intravascular coagulation (DIC) might shorten patients' hospital stay and fatality rates.A serious clinical syndrome called disseminated intravascular coagulation manifests as systemic activation of the homeostatic system, which increases...

Login or Register to read the full article

A new study published in the International Journal of Clinical Practice suggests that heparin introduction during early stages of disseminated intravascular coagulation (DIC) might shorten patients' hospital stay and fatality rates.

A serious clinical syndrome called disseminated intravascular coagulation manifests as systemic activation of the homeostatic system, which increases thrombin deposition and produces microvascular thrombi. Heparin works well to treat hypercoagulability conditions by inhibiting thrombin. The current study by Navid Omidkhoda and colleagues attempted to synthesize and analyze the findings of cohort studies and randomized clinical trials addressing the impact of heparin and its preparations on DIC mortality and hospitalization time.

After screening the remaining 2538 articles, which numbered 3288 in total but contained 750 duplicate entries, the initial systematic literature search produced 3288 articles. A total of 62 articles were reviewed through the complete texts after the screening of titles and abstracts resulted in the exclusion of 2473 records, leaving 65 articles available for retrieval. Three of these articles were not retrievable.

The key findings of this extensive review:

  • Eight papers were qualified to be included in this analysis out of 3288 publications.
  • Six RCTs and two retrospective cohort studies with 950 people who had DIC diagnoses were found in this analysis.
  • Four trials found that heparin had a substantial impact on DIC mortality.
  • In three trials, heparin served as the control group.

In conclusion, it can be put forth that giving heparin and its preparations to DIC patients may shorten their stay in the hospital and lower their death rate, especially if they receive them early in the course of their illness.

Reference: 

Omidkhoda, N., Abedi, F., Ghavami, V., Rahimi, H., Samadi, S., Arasteh, O., & Mohammadpour, A. H. (2022). The Effect of Heparin and Its Preparations on Disseminated Intravascular Coagulation Mortality and Hospitalization: A Systematic Review. In A. Mansour (Ed.), International Journal of Clinical Practice (Vol. 2022, pp. 1–9). Hindawi Limited. https://doi.org/10.1155/2022/2226761

Tags:    
Article Source : Hindawi Limited

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News